Algorae Pharmaceuticals Limited
1AI
Pozycja w akcjach
#30817
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Cena akcji
$0.00702515
Kapitalizacja rynkowa
$14.24M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-30.99%
Kraj
AU
Handel Algorae Pharmaceuticals Limited (1AI)
Kategoria
Healthcare
Historia ceny akcji dla Algorae Pharmaceuticals Limited (1AI)
Najwyższa cena zamknięcia: $0.01 dnia 2023-10-01
Najniższa cena zamknięcia: $0.18 dnia 2004-08-01
Najniższa cena zamknięcia: $0.18 dnia 2004-08-01
Historia cen akcji firmy Algorae Pharmaceuticals Limited od 2004 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2023 | 6.81% |
| 2022 | 127.17% |
| 2021 | -62.32% |
| 2020 | -1.87% |
| 2019 | -62.42% |
| 2018 | 44.81% |
| 2017 | -68.09% |
| 2016 | 92.42% |
| 2015 | -37.24% |
| 2014 | -34.11% |
| 2013 | 61.27% |
| 2012 | 1.22% |
| 2011 | -64.54% |
| 2010 | -38.56% |
| 2009 | 207.71% |
| 2008 | -77.10% |
| 2007 | 101.95% |
| 2006 | -3.09% |
| 2005 | -54.59% |
| 2004 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $755.78 | 7.42% |
CH
|
